Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis.
Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis.
复制标题
益生菌衍生的铁晶体通过JNK介导的凋亡抑制结肠癌的进展。
DOI:
10.1038/ncomms12365
复制
发表时间:
2016-08-10
影响因子:
16.6
通讯作者:
Kohgo Y
中科院分区:
文献类型:
--
作者:
Konishi H;Fujiya M;Tanaka H;Ueno N;Moriichi K;Sasajima J;Ikuta K;Akutsu H;Tanabe H;Kohgo Y
Previous reports have suggested that some probiotics inhibit tumorigenesis and cancer progression. However, the molecules involved have not yet been identified. Here, we show that the culture supernatant of Lactobacillus casei ATCC334 has a strong tumour-suppressive effect on colon cancer cells. Using mass spectrometry, we identify ferrichrome as a tumour-suppressive molecule produced by L. casei ATCC334. The tumour-suppressive effect of ferrichrome is greater than that of cisplatin and 5-fluorouracil, and ferrichrome has less of an effect on non-cancerous intestinal cells than either of those agents. A transcriptome analysis reveals that ferrichrome treatment induces apoptosis, which is mediated by the activation of c-jun N-terminal kinase (JNK). Western blotting indicates that the induction of apoptosis by ferrichrome is reduced by the inhibition of the JNK signalling pathway. This we demonstrate that probiotic-derived ferrichrome exerts a tumour-suppressive effect via the JNK signalling pathway. Probiotics have tumour-suppressive effects in cancer cell lines and in animal models. In this study, the authors demonstrate that ferrichrome produced by Lactobacillus casei ATCC334 can suppress colon cancer growth inducing apoptosis via the JNK pathway.